Thoma Bravo has announced the completion of its affiliate's acquisition of kneat.com, inc., the global leader in digital validation and quality process automation, in an all-cash transaction valued at approximately C$650 million. The agreement was overwhelmingly approved by shareholders and the transaction closed with shareholders receiving C$6.50 per share in cash.
Thoma Bravo completes C$650M acquisition of Kneat.
Shareholders receive C$6.50 per share in cash.
Kneat Gx platform reduces validation documentation man-hours by up to 50%.
Accelerates review and approval cycles by up to 50%.
ISO 9001 and ISO 27001 certified, 21 CFR Part 11/Annex 11 compliant.
Kneat shares will be delisted from Toronto Stock Exchange on August 12, 2026.
Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. The platform is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Optional AI capabilities within Kneat Gx accelerate the validation lifecycle, from content generation to review and analysis, while maintaining full GxP compliance, governance, and data integrity. Multiple independent customer studies have shown that Kneat Gx reduces man-hours associated with validation documentation by up to 50%, accelerates review and approval cycles by up to 50%, and consistently supports higher standards of regulatory compliance.
With the strategic backing of Thoma Bravo, Kneat looks forward to expanding the reach of the Kneat Gx platform, serving life sciences partners even more effectively, and defining the future of digital validation and regulatory compliance automation. Thoma Bravo is the world's largest software-focused investment firm, with more than $172 billion in assets under management.
"Today marks an important milestone on the continued evolution of Kneat," said Eddie Ryan, CEO and co-founder of Kneat. "Our growth from being an idea nearly 20 years ago into the world's leading digital validation platform for life sciences companies has been rewarding, and we're excited to continue on to the next leg of the journey. With the strategic backing of Thoma Bravo, we look forward to expanding the reach of the Kneat Gx platform, serving our life sciences partners even more effectively, and defining the future of digital validation and regulatory compliance automation."
"We are pleased to complete this transaction which reflects our strong confidence in Kneat's mission-critical technology, exceptional management team, and loyal enterprise customer base," said Chandler Gay, a Senior Vice President at Thoma Bravo. "Kneat has established itself as a vital platform for life sciences and highly regulated enterprises, and is well positioned to capitalize on growing market demand and increasing validation complexity. We look forward to deploying our operational expertise to help them scale, innovate, and extend their market leadership as a private company."
About Kneat
Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy.
About Thoma Bravo
Thoma Bravo is the world's largest software-focused investment firm, with more than $172 billion in assets under management as of March 31, 2026. Partnering with some of the world's most sophisticated investors, Thoma Bravo's private equity and private credit platforms reflect a focused investment strategy, supported by disciplined execution, deep sector expertise, and leadership continuity.
